Clinical Trial Update: Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating whether two Naftifine HCl 1% Cream formulations are clinically equivalent in patients with interdigital tinea pedis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Naftifine HCl 1% Cream (naftifine hydrochloride 1% cream)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Tinea Pedis | Phase 1 | Status: COMPLETED